Lara Bloom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How to care for a pet cloud; overcoming bullies; a powerful tale of Muslim identity; a YA sci‑fi thriller, and more

(CNN) — One day in July 2021, my then 15-year-old daughter Poppy stumbled and fell while walking down some stairs, grazing her knee. It wasn’t a serious wound, but over the weeks it didn’t heal. Around the same time, her wrists and knees became sore; her ankles started rolling when she walked; her hands began […]

One day in July 2021, my then 15-year-old daughter Poppy stumbled and fell while walking down some stairs, grazing her knee. It wasn't a serious wound, but over the weeks it didn't heal. I took Poppy to doctors who conducted tests, but they couldn't find out what was wrong with her. Then, in October, a breakthrough.

Richmond, VA (PRWEB) August 12, 2022 -- Christie Cox, a patient and advocate who suffers from hypermobile Ehlers Danlos syndrome (EDS), announced today the

(0) Aytu gains global license to pivotal study-ready protein kinase C β isoform (PKCβ) inhibitor, AR101 (enzastaurin) in rare disease indications Program initially targeting vascular Ehlers-Danlos Syndrome (vEDS), a rare inherited connective tissue disorder resulting in high morbidity and a significantly shortened life span with no FDA-approved treatments Rumpus co-founders Christopher Brooke and Nathaniel Massari to join Aytu executive team with responsibility for AR101 program and development of pediatric onset rare disease pipeline Company to host conference call today at 4:30 PM ET ...